Holiday Gift Guide »

AT&T reports Q4 2012 earnings, record 10.2M total smartphones, 8.6M iPhones

Categories: Android, AT&T, iOS / iPhone OS
By: , IntoMobile
Thursday, January 24th, 2013 at 1:45 PM

AT&T announced its quarterly earnings for Q4 2012 and the carrier’s smartphone sales were through the roof. AT&T sold 10.2 million smartphones in Q4 2012, up from the 6.1 million it sold in the previous quarter. The iPhone was the dominant smartphone – with a record 8.6 million activations. AT&T also said it had its best ever quarter for Android activations.

AT&T also announced quarterly revenues of $32.6 billion, a 0.2% year over year increase, and beat the street, which predicted $32.2 billion in revenue. Earnings per share came in at $0.44, which was slightly below the expected $0.46. Other highlights include

  • Wireless revenues up 5.7 percent versus the year-ago quarter; wireless service revenues up 4.2 percent
  • 780,000 wireless postpaid net adds, largest increase in three years; 1.1 million increase in total net wireless subscribers
  • Record smartphone sales of 10.2 million, the most ever sold by any U.S. carrier; postpaid smartphone customer base now 47.1 million, up 2.5 million from third-quarter 2012
  • Smartphones 89 percent of postpaid phone sales
  • Postpaid wireless subscriber ARPU (average monthly revenues per subscriber) up 1.9 percent to $64.98
You can read the additional details on wireline and overall performance in the press release on AT&T’s website.
[Via AT&T]

About The Author

Kelly Hodgkins

Kelly spent the last four years covering mobile technology at places like BGR, Gizmodo and The Unofficial Apple Weblog. Before writing, she spent a few years working with and teaching others how to use Adobe Flash and Macromedia Director. Even earlier than that, she spent several years as a Ph.D student in Microbiology. When she's not writing, she can be found fishing the lakes and hiking the mountains of Western Maine with her husband and tribe of children. You can follow her on Twitter @kellyhodgkins.